Követés
Simon M. Vogel
Simon M. Vogel
Bayer Pharma AG
E-mail megerősítve itt: bayer.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
Evaluation and optimization of virtual screening workflows with DEKOIS 2.0–a public library of challenging docking benchmark sets
MR Bauer, TM Ibrahim, SM Vogel, FM Boeckler
Journal of chemical information and modeling 53 (6), 1447-1462, 2013
1532013
DEKOIS: Demanding Evaluation Kits for Objective in Silico Screening  A Versatile Tool for Benchmarking Docking Programs and Scoring Functions
SM Vogel, MR Bauer, FM Boeckler
Journal of chemical information and modeling 51 (10), 2650-2665, 2011
832011
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2
SM Vogel, MR Bauer, AC Joerger, R Wilcken, T Brandt, DB Veprintsev, ...
Proceedings of the National Academy of Sciences 109 (42), 16906-16910, 2012
652012
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
M Abdel-Halim, AB Keeton, E Gurpinar, BD Gary, SM Vogel, M Engel, ...
Bioorganic & medicinal chemistry 21 (23), 7343-7356, 2013
92013
Use of DEKOIS 2.0 to gain insights for virtual screening
FM Boeckler, MR Bauer, TM Ibrahim, SM Vogel
Journal of Cheminformatics 6, 1-1, 2014
82014
Potentiometric determination of ionisation constants for diphacinone and chlorophacinone in a dioxane–water cosolvent system
J Chan, SM Vogel, J Wen, RG Alany
Journal of pharmaceutical and biomedical analysis 50 (1), 86-89, 2009
82009
New targets addressed by DEKOIS 2.0: Demanding evaluation kits for objective in-silico screening
FM Boeckler, MR Bauer, TMIM Abdelrehim, SM Vogel
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
2013
From DEKOIS to LCA-applied virtual screening and biophysical studies on cancer targets and their impact on refinement of in Silico methods
SM Vogel
2012
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–8